885
Views
19
CrossRef citations to date
0
Altmetric
Articles

The determination of acrylamide content in brewed coffee samples marketed in Turkey

ORCID Icon, ORCID Icon & ORCID Icon
Pages 280-287 | Received 01 Aug 2019, Accepted 20 Oct 2019, Published online: 07 Nov 2019
 

ABSTRACT

Coffee is a beverage that is widely enjoyed and consumed by all segments of society. As well as having a rich content, it contains acrylamide, defined as ‘a probable carcinogen for humans’ by the International Agency for Research on Cancer. The aim of this study was both to determine the acrylamide levels of ready-to-drink coffees from various coffee brands marketed in Turkey and to offer a resource for risk assessment and acrylamide exposure studies in this area. For this purpose, a total of 41 coffee samples (22 instant coffee, 7 traditional Turkish coffee and 12 ready-to-drink (brewed) coffee) obtained from local markets and coffee shops were analysed in terms of acrylamide content. LC-MS/MS was used to detect the acrylamide content in the samples. The levels of acrylamide ranged from 16.5 to 79.5 ng mL−1 in instant coffees, from 5.9 to 38.8 ng mL−1 in ready-to-drink (brewed) coffees and from 5.3–54.8 ng mL−1 in Turkish coffee and other traditional coffees. The study showed that instant coffee includes the highest level of acrylamide among the other types. In addition, it was found that terebinth coffee, a form of traditional Turkish coffee, had a high content of acrylamide.

Acknowledgments

This study was carried out in the laboratories of Eastern Anatolia Advanced Technologies Research and Application Center (DAYTAM).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was funded by Atatürk University Coordination Center of Scientific Research Projects [FDK-2018-6675].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.